Independently verified Tested by an accredited US third-party lab for identity, purity, and concentration
Beyond vascular effects, BPC-157 activates the FAK-paxillin signaling pathway, which drives cell migration and adhesion two processes critical for wound closure and tissue remodeling
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
Browse our full Certificates of Analysis archive and learn about our Quality & Testing process
Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher
Follow the product label and any lot-specific documentation